Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Citi
Daiichi Sankyo
Dow
Farmers Insurance
Queensland Health
Baxter
UBS
Moodys
Argus Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: empagliflozin; metformin hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0280-7330 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0280-73)
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0280-361 BOTTLE in 1 CARTON (0597-0280-36) > 7 TABLET, EXTENDED RELEASE in 1 BOTTLE
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0280-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0280-90)
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0290-201 BOTTLE in 1 CARTON (0597-0290-20) > 14 TABLET, EXTENDED RELEASE in 1 BOTTLE
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0290-7460 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0290-74)
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0290-59180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0290-59)
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0295-611 BOTTLE in 1 CARTON (0597-0295-61) > 7 TABLET, EXTENDED RELEASE in 1 BOTTLE
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0295-7890 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0295-78)
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0295-8830 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0295-88)
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0300-93180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-93)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
US Department of Justice
Dow
Healthtrust
Covington
Chinese Patent Office
Citi
AstraZeneca
Merck

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot